SNMMI 2022 Meeting
SNMMI 2022 Meeting
Society of Nuclear Medicine and Molecular Imaging 2022 Annual Meeting
Kerri FitzgeraldSNMMI 2022 Meeting | June 15, 2022
Piflufolastat F 18 is a radiopharmaceutical that targets the prostate-specific membrane antigen during imaging.
Read More
Kerri FitzgeraldSNMMI 2022 Meeting | June 15, 2022
This model assigns workers to additional or alternate roles that match existing skills and providing proper re-training.
Kerri FitzgeraldSNMMI 2022 Meeting | June 15, 2022
Researchers retrospectively analyzed patients who had received both 68Ga-PSMA PET/CT and mpMRI testing.
Kerri FitzgeraldSNMMI 2022 Meeting | June 15, 2022
The approach may help inform clinical decision-making early in treatment.
Kerri FitzgeraldSNMMI 2022 Meeting | June 15, 2022
Updates may be needed to guidelines for salvage radiation treatments in patients with local recurrence of prostate cancer.
Kerri FitzgeraldSNMMI 2022 Meeting | June 14, 2022
Developers and users must be aware of the potential for data attacks and manipulation when considering AI models for imaging.
Kerri FitzgeraldSNMMI 2022 Meeting | June 14, 2022
The authors of the study won the 2022 SNMMI Abstract of the Year Award.
Kerri FitzgeraldSNMMI 2022 Meeting | June 14, 2022
The novel artificial intelligence can produce high-quality PET/CT images while decreasing radiation exposure to patients.
Kerri FitzgeraldSNMMI 2022 Meeting | June 14, 2022
Researchers conducted a prospective phase 2 imaging study to compare PSMA and GRP-R-targeted imaging during initial staging.
Kerri FitzgeraldSNMMI 2022 Meeting | June 12, 2022
Guided imagery can enhance coping, reduce anxiety, and decrease heart rate, respirations, and blood pressure.
Kerri FitzgeraldSNMMI 2022 Meeting | June 12, 2022
A study explore values of parametric Ki imaging in total-body 68Ga-PSMA-11 PET/CT in patients with prostate cancer.
Kerri FitzgeraldSNMMI 2022 Meeting | June 12, 2022
The framework emphasizes the importance of establishing trust among stakeholders.
Kerri FitzgeraldSNMMI 2022 Meeting | June 12, 2022
The study is the first to show that lingering COVID-19 symptoms can be attributed to ongoing lung inflammation.
Robert DillardJournal | December 14, 2021
During an SNMMI Annual Meeting scientific session, researchers discussed imaging modalities to diagnose different cancers.
Advertisement
Advertisement